ARTICLE | Company News
NPS, DRI Capital in royalty deal
March 3, 2010 1:51 AM UTC
NPS Pharmaceuticals Inc. (NASDAQ:NPSP) sold its royalty rights for Regpara cinacalcet in Japan and other Asian countries to DRI Capital for $38.4 million. The deal covers royalties from Kyowa Hakko Ki...